Discovery of a benzoxazine derivative promoting angiogenesis in vitro and in vivo

Journal of Cellular Physiology

Volumn 223, Issue 1, 2010, Pages 202-208

  Dong, Zhiwu ^a,b   Cheng, Yizhe ^a,b   Zhao, Jing ^a,b   Su, L E ^a,b   Zhao, Baoxiang ^a   Zhang, Yun ^b   Zhang, Shangli ^a,b   Miao, Junying ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINO 2,3 DIHYDRO 3 HYDROXYMETHYL 1,4 BENZOXAZINE; BENZOXAZINE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MATRIGEL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BENZOXAZINES; CELL MOVEMENT; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 75749105043     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22025     Document Type: Article

References (28)

1. Baeriswyl V, Christofori G. 2009. The angiogenic switch in carcinogenesis. Semin Cancer Biol 19:329-337.
2. Blanchetot C, Boonstra J. 2008. The ROS-NOX connection in cancer and angiogenesis. Crit Rev Eukaryot Gene Expr 18:35-45.
3. Chen Z, Joshi S, Kauser K, Brooks AR. 2007. Knockdown of endothelial NOS by lentivirusmediated short hairpin RNA in hemangioendothelioma cells increases proliferation and tumor formation. Nitric Oxide 16:403-412.
4. Cross MJ, Claesson-Welsh L. 2001. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201-207.
5. Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre JS. 2006.NADPHoxidase- derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 169:719-728.
6. Falchi AM, Isola R, Diana A, Putzolu M, Diaz G. 2005. Characterization of depolarization and repolarization phases of mitochondrial membrane potential fluctuations induced by tetramethylrhodamine methyl ester photoactivation. FEBS J 272:1649-1659.
7. Igarashi J, Michel T. 2008. S1P and eNOS regulation. Biochim Biophys Acta 1781:489-495. Ignarro LJ. 2002. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53:503-514.
8. Ilas J, Jakopin Z, Borstnar T, Stegnar M, Kikelj D. 2008. 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function. J Med Chem 51:5617-5629.
9. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. JClin Invest 52:2745-2756.
10. Jiao PF, Zhao BX,WangWW,HeQX,WanMS, Shin DS,Miao JY. 2006. Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl- 1,4-benzoxazine derivatives. Bioorg Med Chem Lett 16:2862-2867.
11. Koini EN, Papazafiri P, Vassilopoulos A, Koufaki M, Horvath Z, Koncz I, Virag L, Papp GJ, Varro A, Calogeropoulou T. 2009. 5,7,8-Trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemiareperfusion injury. J Med Chem 52:2328-2340.
12. Korystov YN, Shaposhnikova VV, Korystova AF, Emel'yanov MO. 2007. Detection of reactive oxygen species induced by radiation in cells using the dichlorofluorescein assay. Radiat Res 168:226-232.
13. La DS, Belzile J, Bready JV, Coxon A, DeMelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF, Harriman SP, Larrow JF, Long AM, MartinMW,MorrisonMJ, Patel VF, Roveto PM, Wang L, Weiss MM, Whittington DA, Teffera Y, Zhao Z, Polverino AJ, Harmange JC. 2008. Novel 2,3-dihydro-1,4- benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis. J Med Chem 51:1695-1705.
14. Lawley TJ, Kubota Y. 1989. Induction of morphologic differentiation of endothelial cells in culture. J Invest Dermatol 93:59S-61S.
15. Li JM, Mullen AM, Yun S, Wientjes F, Brouns GY, Thrasher AJ, Shah AM. 2002. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 90:143-150.
16. Luque CD, Vargas RH, Romo E, Rios A, Escalante B. 2006. The role of nitric oxide in the postischemic revascularization process. Pharmacol Ther 112:553-563.
17. Lv X, Su L, YinD, Sun C, Zhao J, Zhang S, Miao J. 2008. Knockdown of integrin beta4 in primary cultured mouse neurons blocks survival and induces apoptosis by elevating NADPH oxidase activity and reactive oxygen species level. Int J Biochem Cell Biol 40:689-699.
18. Nomi M, Miyake H, Sugita Y, Fujisawa M, Soker S. 2006. Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther 1:333-343.
19. Piao ZH, Yoon SR, Kim MS, Jeon JH, Lee SH, Kim TD, Lee HG, Bae KH, Min JK, Chung SJ, Kim M, Cho YS, Oh DB, Park SY, Chung JW, Choi I. 2009. VDUP1 potentiates Ras-mediated angiogenesis via ROS production in endothelial cells. Cell Mol Biol (Noisy -le-grand) 55:OL1096-OL1103.
20. Ponce ML. 2009. Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol Biol 467:183-188.
21. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, Presta M. 1997. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res 34:455-463.
22. Ryan US, Absher M, Olazabal BM, Brown LM, Ryan JW. 1982. Proliferation of pulmonary endothelial cells: time-lapse cinematography of growth to confluence and restitution of monolayer after wounding. Tissue Cell 14:637-649.
23. Slavin J. 1995. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19:431-444.
24. Spring DR. 2005. Chemical genetics to chemical genomics: small molecules offer big insights. Chem Soc Rev 34:472-482.
25. Ushio-Fukai M. 2006. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 71:226-235.
26. Ushio-Fukai M. 2007. VEGF signaling throughNADPHoxidase-derived ROS. Antioxid Redox Signal 9:731-739.
27. Ushio-Fukai M. 2009. Novel role ofNADPHoxidase in angiogenesis and stem/progenitor cell function. Antioxid Redox Signal 11:2517-2533.
28. Ying L, Hofseth LJ. 2007. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 67:1407-1410.